Nathan D. Grubaugh

25.7k total citations · 5 hit papers
90 papers, 3.7k citations indexed

About

Nathan D. Grubaugh is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Insect Science. According to data from OpenAlex, Nathan D. Grubaugh has authored 90 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Infectious Diseases, 50 papers in Public Health, Environmental and Occupational Health and 14 papers in Insect Science. Recurrent topics in Nathan D. Grubaugh's work include Mosquito-borne diseases and control (46 papers), Viral Infections and Vectors (36 papers) and SARS-CoV-2 and COVID-19 Research (28 papers). Nathan D. Grubaugh is often cited by papers focused on Mosquito-borne diseases and control (46 papers), Viral Infections and Vectors (36 papers) and SARS-CoV-2 and COVID-19 Research (28 papers). Nathan D. Grubaugh collaborates with scholars based in United States, United Kingdom and Belgium. Nathan D. Grubaugh's co-authors include Kristian G. Andersen, Doug E. Brackney, Gregory D. Ebel, Akiko Iwasaki, Edward C. Holmes, Oliver G. Pybus, Joseph R. Fauver, Chantal B. F. Vogels, Albert I. Ko and Jason T. Ladner and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Nathan D. Grubaugh

81 papers receiving 3.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Measurement of SARS-CoV-2 RNA in wastewater tracks community infection dynamics

2020 640 citations Doug E. Brackney, Nathan D. Grubaugh et al. profile →
An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar

2019 459 citations Nathan D. Grubaugh, Karthik Gangavarapu et al. profile →
Tracking virus outbreaks in the twenty-first century

2018 243 citations Nathan D. Grubaugh, Philippe Lemey et al. profile →
Persistent SARS-CoV-2 infection: significance and implications

2024 69 citations Anne M. Hahn, Nathan D. Grubaugh et al. profile →
Contribution of climate change to the spatial expansion of West Nile virus in Europe

2024 51 citations Chantal B. F. Vogels, Nathan D. Grubaugh et al. Nature Communications profile →

Peers

Countries citing papers authored by Nathan D. Grubaugh

Since Specialization

Citations

This map shows the geographic impact of Nathan D. Grubaugh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan D. Grubaugh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan D. Grubaugh more than expected).

Fields of papers citing papers by Nathan D. Grubaugh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathan D. Grubaugh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan D. Grubaugh. The network helps show where Nathan D. Grubaugh may publish in the future.

Co-authorship network of co-authors of Nathan D. Grubaugh

This figure shows the co-authorship network connecting the top 25 collaborators of Nathan D. Grubaugh. A scholar is included among the top collaborators of Nathan D. Grubaugh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan D. Grubaugh. Nathan D. Grubaugh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dengue Outbreak Caused by Multiple Virus Serotypes and Lineages, Colombia, 2023–2024 2024 ·Emerging infectious diseases ·Nathan D. Grubaugh, (unknown), (unknown), Diana Dávalos, Pío López, Isabel Cristina Hurtado, Mallery I. Breban, (unknown), Verity Hill, Eduardo López-Medina	3
2	Analysis of Powassan Virus Genome Sequences from Human Cases Reveals Substantial Genetic Diversity with Implications for Molecular Assay Development 2024 ·Viruses ·(unknown), (unknown), (unknown), Isaac H. Solomon, Sam R. Telford, Matthew T. Aliota, Chantal B. F. Vogels, Nathan D. Grubaugh, Jeffrey Helgager, Holly R. Hughes, Jason O. Velez, Anne Piantadosi, (unknown), Jacob E. Lemieux, John A. Branda	0
3	Genome-wide association study between SARS-CoV-2 single nucleotide polymorphisms and virus copies during infections 2024 ·PLoS Computational Biology ·(unknown), Chrispin Chaguza, (unknown), (unknown), (unknown), David Ferguson, (unknown), (unknown), Wade L. Schulz, (unknown), Anne M. Hahn, C. Brandon Ogbunugafor, Virginia E. Pitzer, Lorin Crawford, Daniel M. Weinberger, Nathan D. Grubaugh	1
4	Viral kinetics of sequential SARS-CoV-2 infections 2023 ·Nature Communications ·Stephen M. Kissler, James A. Hay, Joseph R. Fauver, Christina Mack, Caroline G. Tai, Deverick J. Anderson, David D. Ho, Nathan D. Grubaugh, Yonatan H. Grad	12
5	Phylogeographic reconstruction of the emergence and spread of Powassan virus in the northeastern United States 2023 ·Proceedings of the National Academy of Sciences ·Chantal B. F. Vogels, Doug E. Brackney, Alan P. Dupuis, Rebecca M. Robich, Joseph R. Fauver, Anderson F. Brito, Scott C. Williams, John F. Anderson, Charles Lubelczyk, (unknown), Melissa A. Prusinski, Laura D. Kramer, (unknown), Laura B. Goodman, Guy Baele, Robert P. Smith, Philip M. Armstrong, Alexander T. Ciota, Simon Dellicour, Nathan D. Grubaugh	22
6	Nonsystematic Reporting Biases of the SARS-CoV-2 Variant Mu Could Impact Our Understanding of the Epidemiological Dynamics of Emerging Variants 2023 ·Genome Biology and Evolution ·Mary E. Petrone, Carolina Lucas, Bridget L. Menasché, Mallery I. Breban, İnci Yıldırım, Melissa Campbell, Saad B. Omer, Edward C. Holmes, Albert I. Ko, Nathan D. Grubaugh, Akiko Iwasaki, Craig B. Wilen, Chantal B. F. Vogels, Joseph R. Fauver	0
7	Identification and characterization of novel lineage 1 Powassan virus strains in New York State 2022 ·Emerging Microbes & Infections ·(unknown), Alan P. Dupuis, Melissa A. Prusinski, Joseph G. Maffei, Cheri A. Koetzner, Kiet Ngo, Bryon Backenson, JoAnne Oliver, Chantal B. F. Vogels, Nathan D. Grubaugh, Laura D. Kramer, Alexander T. Ciota	11
8	Sequencing SARS-CoV-2 genomes from saliva 2021 ·Virus Evolution ·Tara Alpert, Chantal B. F. Vogels, Mallery I. Breban, Mary E. Petrone, Anne L. Wyllie, Nathan D. Grubaugh, Joseph R. Fauver	6
9	An outbreak of SARS‐CoV‐2 on a transplant unit in the early vaccination era 2021 ·Transplant Infectious Disease ·Scott C. Roberts, (unknown), Nathan D. Grubaugh, Tara Alpert, Isabel M. Ott, Mallery I. Breban, (unknown), Richard A. Martinello, (unknown), Matthew W. Davis, Dayna McManus, (unknown), Jeffrey Topal, Marwan M. Azar, Maricar Malinis	5
10	Multiple Transmission Chains within COVID-19 Cluster, Connecticut, USA, 20201 2021 ·Emerging infectious diseases ·Stephen M. Bart, (unknown), Tara Alpert, (unknown), (unknown), Rebecca Earnest, Elizabeth B. White, (unknown), Anderson F. Brito, Nathan D. Grubaugh, James L. Hadler, Lynn Sosa	5
11	MOG-associated encephalitis following SARS-COV-2 infection 2021 ·Multiple Sclerosis and Related Disorders ·John Peters, (unknown), Chantal B. F. Vogels, Nathan D. Grubaugh, Shelli Farhadian, Erin E. Longbrake	42
12	COVID-19 one year into the pandemic: from genetics and genomics to therapy, vaccination, and policy 2021 ·Human Genomics ·Giuseppe Novelli, Michela Biancolella, Ruty Mehrian‐Shai, Vito Luigi Colona, Anderson F. Brito, Nathan D. Grubaugh, Vasilis S. Vasiliou, Lucio Luzzatto, Juergen Reichardt	27
13	Densely sampled viral trajectories suggest longer duration of acute infection with B.1.1.7 variant relative to non-B.1.1.7 SARS-CoV-2 2021 ·Digital Access to Scholarship at Harvard (DASH) (Harvard University) ·Stephen M. Kissler, Joseph R. Fauver, Christina Mack, Caroline G. Tai, Mallery I. Breban, Anne E. Watkins, (unknown), Deverick J. Anderson, David D. Ho, Nathan D. Grubaugh, Yonatan H. Grad	33
14	COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants 2021 ·Cell ·Müge Çevik, Nathan D. Grubaugh, Akiko Iwasaki, Peter Openshaw	88
15	Epidemiological hypothesis testing using a phylogeographic and phylodynamic framework 2020 ·Nature Communications ·Simon Dellicour, Sébastian Lequime, Bram Vrancken, Mandev S. Gill, Paul Bastide, Karthik Gangavarapu, Nathaniel L. Matteson, Yi Tan, Louis du Plessis, (unknown), Martha I. Nelson, Marius Gilbert, Marc A. Suchard, Kristian G. Andersen, Nathan D. Grubaugh, Oliver G. Pybus, Philippe Lemey	37
16	Arbovirus coinfection and co-transmission: A neglected public health concern? 2019 ·PLoS Biology ·Chantal B. F. Vogels, Claudia Rückert, Sean Cavany, T. Alex Perkins, Gregory D. Ebel, Nathan D. Grubaugh	117
17	Adventitious viruses persistently infect three commonly used mosquito cell lines 2018 ·Virology ·James Weger‐Lucarelli, Claudia Rückert, Nathan D. Grubaugh, (unknown), Philip M. Armstrong, Mark D. Stenglein, Gregory D. Ebel, Doug E. Brackney	26
18	Experimental Evolution to Study Virus Emergence 2017 ·Cell ·Nathan D. Grubaugh, Kristian G. Andersen	23
19	Dynamics of West Nile virus evolution in mosquito vectors 2016 ·Current Opinion in Virology ·Nathan D. Grubaugh, Gregory D. Ebel	36
20	Isolation of a Novel Insect-Specific Flavivirus from Culiseta melanura in the Northeastern United States 2016 ·Vector-Borne and Zoonotic Diseases ·(unknown), Nathan D. Grubaugh, Theodore G. Andreadis, Gregory D. Ebel, Philip M. Armstrong	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact